Arphra/Issuer/UTHR

UTHR

United Therapeutics Corporation

HealthcareBiotechnologyUSUSD

$544.62

LiveJun 01, 2026

AI Brief

Market cap

$23.12B

52w range

272.12 – 609.35

P / E

—

EPS

—

Volume

469.09K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on United Therapeutics Corporation’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

$2.47M

10 txns

Net flow

−$2.47M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for UTHR.

Peers

No peer list available for UTHR.

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-2.19%	-5.90%	-4.52%	+8.08%	+13.47%	+11.77%	+67.33%	+155.12%	+206.28%	+357.20%	+8837.35%

Aftermarket

Live

Jun 01, 08:22 PM

Last trade

$541.50

116 sh

Bid

$528.00

2 sh

Ask

$555.00

27 sh

Spread

$27.000

Sector & industry today

Live

Sectors

Technology
+3.35%
Basic Materials
+0.94%
Energy
+0.84%
Consumer Cyclical
+0.48%
Industrials
+0.26%
Communication Services
+0.16%
Financial Services
-0.80%
Healthcare
-0.83%
Consumer Defensive
-0.84%
Utilities
-1.17%
Real Estate
-1.32%

Top industries (issuer's industry highlighted)

Biotechnology
-2.47%
Computer Hardware
+8.82%
Software - Infrastructure
+8.14%
Coal
+5.93%
Broadcasting
+5.36%
Consulting Services
+4.97%
Manufacturing - Metal Fabrication
+4.57%
Staffing & Employment Services
+4.49%
Integrated Freight & Logistics
+4.19%
Gambling, Resorts & Casinos
+3.99%
Software - Application
+3.94%
Medical - Equipment & Services
+3.52%

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $636.83 (+16.93%)

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	56	$32.67K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	106	$60.6K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	240	$136.52K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	293	$167.92K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	400	$228.13K	May 12, 2026
ROTHBLATT MARTINE A director, officer: Chairperson & CEO	Sell	401	$230.05K	May 12, 2026

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin